Lexston Life Sciences Corp
  • Home
  • The Company
    • About Lexston
    • Officers & Directors
    • Investors
    • News Releases
    • Legal, Banking & T/A
    • Projects
  • Contact Us
  • More
    • Home
    • The Company
      • About Lexston
      • Officers & Directors
      • Investors
      • News Releases
      • Legal, Banking & T/A
      • Projects
    • Contact Us
  • Sign In
  • Create Account
  • My Account

  • Signed in as:

  • filler@godaddy.com

  • My Account

  • Sign out

Lexston Life Sciences Corp

Signed in as:

filler@godaddy.com

  • Home
  • The Company
    • About Lexston
    • Officers & Directors
    • Investors
    • News Releases
    • Legal, Banking & T/A
    • Projects
  • Contact Us

Account

  • My Account

  • Sign out

  • Sign In
  • My Account

News Releases November 15,2023 onwards

November 27, 2023 Nunavut Uranium Properties (pdf)Download
November 16, 2023 Frankfurt listing details (pdf)Download
November 15, 2023 LOOKING TO ACQUIRE URANIUM ASSETS (pdf)Download

News releases July 2022 to November 14, 2023

November, 8, 2023 Results of AGSM (pdf)Download
October 19, 2023 Change of Business and Change of Name (pdf)Download
June 28, 2023 change of auditors (pdf)Download
June 2, 2023 Filing of NI 43-101 technical Report (pdf)Download
May 31, 2023 Amendment to property option (pdf)Download
March 3, 2023 Rick Walker joins Board of Lexston (pdf)Download
February 24, 2023 Update re Change of Business (pdf)Download
January 18, 2023 Change of Business (pdf)Download
October 17, 2022 Resignation of Director (pdf)Download
October 6, 2022 correction to date for the Stock Option Grant (pdf)Download
October 3, 2022 Stock Option grant (pdf)Download
September 12, 2022 BOD addition (pdf)Download
September 8, 2022 Resignation of Director (pdf)Download
August 11, 2022 Results of Annual General and Special Meeting (pdf)Download
July 4, 2022 Closing of the Private Placement (pdf)Download

News releases January to June | 2022

June 27, 2022 Private Placement increased (pdf)Download
June 15, 2022 resignation of Philippe Henry as Director and CSO (pdf)Download
June 9. 2022 Subsidiaries lay off staff (pdf)Download
June 3, 2022 Cancellation of options (pdf)Download
June 1, 2022 Private Placement (pdf)Download
May 20, 2022 Share Consolidation (pdf)Download
May 13, 2022 Share Consolidation (pdf)Download
April 11, 2022 Allenii Project (pdf)Download
March 25, 2022 appointment of CFO (pdf)Download
Jan 31, 2022 Section 56 exemption (pdf)Download
Jan 24, 2022 Egret-8SNP (pdf)Download
Jan 19, 2022 Egret-NRCirap (pdf)Download
Jan 14, 2022 Market Activity (pdf)Download
Jan 12, 2022 MOU ALVARIUS (pdf)Download
Jan 10 2022 MOU Panacea (pdf)Download

News releases | 2021

Dec 15, 2021 DTC ELIGIBILITY (pdf)Download
Nov 15, 2021 OTC listing (pdf)Download
Nov 11, 2021 Lexston NR re STOCK OPTION GRANT (pdf)Download
Sept 28, 2021 Psy (pdf)Download
Sept 23, 2021 RESEARCH and DEVELOPMENT (pdf)Download
Sept 20, 2021 ACQUISITION OF ZEN (pdf)Download
Sept 9, 2021 LEXT retains marketing consultant (pdf)Download
July 13, 2021 Section 56 update (pdf)Download
July 7, 2021 Psy PP (pdf)Download
July 5, 2021 STOCK OPTION GRANT (pdf)Download
June 30, 2021 BOD Graeme Staley (pdf)Download
June 23, 2021 initial release (pdf)Download
June 21 2021 CSE - New Listing - Lexston Life Sciences Corp_ (pdf)Download

Copyright © 2023 Lexston - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept